Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Tomasz Kucharczyk

Medical University of Lublin

Poland

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

70%

Cell Biology

40%

Cancer Biology

90%

Targeted Therapy

40%

Oncology

30%

Tumor Suppression

30%

Tumor Immunology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles14

Obesity and lung cancer – is programmed death ligand-1 (PD-1L) expression a connection?

Article Link

Year:

2024

NRG1 Gene Fusions—What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications

Article Link

Year:

2024

RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy

Article Link

Year:

2022

Attempting to identify bacterial allies in immunotherapy of NSCLC patients

Article Link

Year:

2022

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer

Article Link

Year:

2022

Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy?

Article Link

Year:

2022

Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer

Article Link

Year:

2022

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement

Article Link

Year:

2021

Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy

Article Link

Year:

2021

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma.

Article Link

Year:

2021

Risk factors and primary prevention of lung cancer. Cessation of cigarette addiction

Article Link

Year:

2021

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients.

Article Link

Year:

2020

Analysis of ROS1 gene rearrangement incidence among NSCLC patients with fluorescent in situ hybridization technique

Article Link

Year:

2020

The search for causes of resistance to pembrolizumab in lung adenocarcinoma with PD-L1 expression - Focus on intestinal microbiome

Article Link

Year:

2020

Collaborators14

Katarzyna Szklener

Medical University of Lublin

POLAND

Justyna Błach

University Children's Hospital

POLAND

Kamila Wojas-Krawczyk

Medical University of Lublin

POLAND

Ewa Kalinka

Polish Mother’s Memorial Hospital Research Institute

POLAND

Michał Gil

Medical University of Lublin

POLAND

Dariusz Kowalski

MD, PhD, Prof

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

Marek Kucharczyk

Maria Curie-Skłodowska University

POLAND

Małgorzata Borowiec-Bar

Medical University of Lublin

POLAND

Dariusz Wasyl

Head of Department/Professor

National Veterinary Research Institute

POLAND

Sławomir Mańdziuk

Medical University of Lublin

POLAND

Małgorzata Frąk

Medical University of Lublin

POLAND

Michał Szczyrek

Medical University of Lublin

POLAND

Marcin Nicos

Associate Professor

Medical University of Lublin

POLAND

Robert Kieszko

lecturer

Medical University of Lublin

POLAND

How do I reach out?

Meet Kite AI